expressed as a daily rate for status 1 or monthly rate for status 2B and 3 patients. The cumulative survival rate is then computed by summing the daily risk for status 1, or monthly risk in the case of status 2B and 3, over time adjusting for the number of subjects remaining on the list at that time point (i.e., adjusted for the competing risk).
All computations were performed using the MIXNO program developed under a grant from the National Institute of Mental Health and available at no charge at http://www.uic.edu/labs/biostat/.
The General Accounting Office (GAO) provided the committee with data that were instrumental in analyzing the potential effects of the Final Rule on transplantation costs. These included data on costs of solid organ transplantation, transportation costs, and costs of assembling a transplantation team. Roger Evans assisted Institute of Medicine staff and the committee in the analysis of these cost issues.